# Comparison of different decellularization protocols for porcine centrum tendineum diaphragmatis and diaphragmatic muscle – a base for effective recellularization

**Authors:** Bruno F. Gaag, Peter Tang, Oliver Klein, Simon Moosburner, Agnes K. Böhm, Theresa Lohmann, Jonas K. Wieland, Victoria Contes, Yijun Zhou, Eriselda Keshi, Luna Haderer, Eric Metzler, Verena Schöwel-Wolf, Simone Spuler, Jens-Carsten Rückert, Johann Pratschke, Igor M. Sauer, Marco N. Andreas, Karl H. Hillebrandt

PMC · DOI: 10.1186/s13036-025-00602-z · Journal of Biological Engineering · 2026-01-07

## TL;DR

This study compares three methods to remove cells from pig diaphragm tissues to find the best way to prepare them for tissue engineering and potential clinical use.

## Contribution

The study evaluates decellularization protocols for porcine diaphragm tissues to improve clinical relevance and recellularization potential.

## Key findings

- All three protocols significantly reduced DNA content in decellularized tissues compared to native tissues.
- P3 preserved the highest amount of proteins, followed by P2 and P1.
- P1 and P2 effectively preserved the extracellular matrix without a clear preference between them.

## Abstract

Diaphragmatic dysfunction results from a variety of diseases or post-surgical conditions, leading to impaired lung function and high morbidity and mortality. Current repair materials are limited by poor biocompatibility, functional incompatibility and immune reactions. Tissue engineering via decellularization offers a promising approach by preserving the extracellular matrix while reducing host immune response. However, most studies have focused on rodent models. This study evaluates three decellularization protocols using porcine tissues to increase clinical relevance and optimize diaphragm repair strategies. We compared detergent-enzymatic treatment (DET) adapted from murine diaphragm developed by Andreas et al. (P1) and two decellularization protocols for larger mammalian diaphragm tissues published by Barbon et al. (P2) for human diaphragm and Deeken et al. (P3) for porcine tendinous diaphragm. Decellularized samples were analyzed using histological analysis, SEM, DNA and GAG quantification and proteomic analysis. DNA content was reduced in decellularized tissues significantly between native and decellularized tissues (native: 990.30 ng/mg (IQR = 556.20); P1: 31.92 ng/mg (IQR = 40.38), P2: 32.38 ng/mg (IQR = 20.83), P3: 106.40 ng/mg (IQR = 811.32). Proteomics revealed 4,640 conserved proteins (5.41% classified as matrisomal proteins). The protocols showed a 55.4% concordance of the preserved matrisomal fraction (n = 139). The highest protein preservation was achieved by P3, followed by P2 and P1. The P1 and P2 protocols are effective in preserving the extracellular matrix while removing cellular components, with no clear preference. Within our laboratory setting, P3 showed decellularization, but did not reach current decellularization standards. This study advances the preparation for clinical translation of a decellularized porcine diaphragm.

The online version contains supplementary material available at 10.1186/s13036-025-00602-z.

## Full-text entities

- **Genes:** ACTN3 (actinin alpha 3) [NCBI Gene 89] {aka ACTN3D}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, MYL1 (myosin light chain 1) [NCBI Gene 4632] {aka CMYO14, CMYP14, MLC-1, MLC1, MLC1/3, MLC1F}, FMOD (fibromodulin) [NCBI Gene 2331] {aka FM, SLRR2E}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, COL1A2 (collagen type I alpha 2 chain) [NCBI Gene 1278] {aka EDSARTH2, EDSCV, OI4}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, MYBPC2 (myosin binding protein C2) [NCBI Gene 4606] {aka MYBPC, MYBPCF, fsMyBP-C}, MYH2 (myosin heavy chain 2) [NCBI Gene 4620] {aka CMYO6, CMYP6, IBM3, MYH2A, MYHSA2, MYHas8}, COL22A1 (collagen type XXII alpha 1 chain) [NCBI Gene 169044], Dnase1 (deoxyribonuclease 1) [NCBI Gene 25633], COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, DCN (decorin) [NCBI Gene 1634] {aka CSCD, DSPG2, PG40, PGII, PGS2, SLRR1B}, MYBPC1 (myosin binding protein C1) [NCBI Gene 4604] {aka CMYO16, CMYP16, LCCS4, MYBPCC, MYBPCS, MYOTREM}, COL6A2 (collagen type VI alpha 2 chain) [NCBI Gene 1292] {aka BTHLM1, BTHLM1B, PP3610, UCMD1, UCMD1B}, COL6A1 (collagen type VI alpha 1 chain) [NCBI Gene 1291] {aka BTHLM1, BTHLM1A, OPLL, UCHMD1, UCHMD1A}, MYH3 (myosin heavy chain 3) [NCBI Gene 4621] {aka CPSFS1A, CPSFS1B, CPSKF1A, CPSKF1B, DA2A, DA2B}, BGN (biglycan) [NCBI Gene 633] {aka DSPG1, MRLS, PG-S1, PGI, SEMDX, SLRR1A}, POSTN (periostin) [NCBI Gene 10631] {aka OSF-2, OSF2, PDLPOSTN, PN}, MYH4 (myosin heavy chain 4) [NCBI Gene 4622] {aka MYH2B, MyHC-2B, MyHC-IIb}, PRELP (proline and arginine rich end leucine rich repeat protein) [NCBI Gene 5549] {aka MST161, MSTP161, SLRR2A}, ACTN2 (actinin alpha 2) [NCBI Gene 88] {aka CMD1AA, CMH23, CMYO8, CMYP8, MPD6, MYOCOZ}
- **Diseases:** atrophy (MESH:D001284), herniation (MESH:D004677), diaphragmatic hernia (MESH:D006548), Muscular dystrophies (MESH:D009136), pulmonary and muscle-degenerative diseases (MESH:D019636), diaphragm defects (MESH:D065630), congenital or acquired defects (MESH:D000013), Diaphragmatic dysfunction (MESH:D056989), diaphragm weakness (MESH:D018908), pulmonary hypertension (MESH:D006976), impaired lung function (MESH:D003072)
- **Chemicals:** acetonitrile (MESH:C032159), ABmod (-), GAG (MESH:D006025), methionine (MESH:D008715), ammonia (MESH:D000641), citrate (MESH:D019343), formaldehyde (MESH:D005557), glutaraldehyde (MESH:D005976), SDS (MESH:D012967), TFA (MESH:D014269), gold (MESH:D006046), Alcian Blue (MESH:D000423), fentanyl (MESH:D005283), DMMB (MESH:C435946), Embutramide (MESH:C059324), methanol (MESH:D000432), 4',6-diamidino-2-phenylindole (MESH:C007293), formic acid (MESH:C030544), Hematoxylin (MESH:D006416), DAB (MESH:C000469), paraffin (MESH:D010232), NaCl (MESH:D012965), hexamethyldisilane (MESH:C520781), Tetracaine (MESH:D013748), water (MESH:D014867), H2O2 (MESH:D006861), alcohol (MESH:D000438), Tergitol (MESH:D011060), streptomycin (MESH:D013307), EtOH (MESH:D000431), EDTA (MESH:D004492), chondroitin sulfate (MESH:D002809), osmium tetroxide (MESH:D009993), Triton  X-100 (MESH:D017830), penicillin (MESH:D010406), P2 (MESH:C020845), palladium (MESH:D010165), H.E. (MESH:D006371), Mebezonium (MESH:C059325), dehydrobenzperidol (MESH:D004329), acid (MESH:D000143), eosin (MESH:D004801), TnbP (MESH:C009524)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12836843/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12836843/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12836843/full.md

---
Source: https://tomesphere.com/paper/PMC12836843